PT3943070T - Long-acting formulations of bedaquiline - Google Patents
Long-acting formulations of bedaquilineInfo
- Publication number
- PT3943070T PT3943070T PT211785266T PT21178526T PT3943070T PT 3943070 T PT3943070 T PT 3943070T PT 211785266 T PT211785266 T PT 211785266T PT 21178526 T PT21178526 T PT 21178526T PT 3943070 T PT3943070 T PT 3943070T
- Authority
- PT
- Portugal
- Prior art keywords
- bedaquiline
- long
- acting formulations
- formulations
- acting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18167463 | 2018-04-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3943070T true PT3943070T (en) | 2024-02-06 |
Family
ID=62002070
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT187398565T PT3651736T (en) | 2018-04-16 | 2018-07-13 | Long-acting formulations |
| PT211785266T PT3943070T (en) | 2018-04-16 | 2018-07-13 | Long-acting formulations of bedaquiline |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT187398565T PT3651736T (en) | 2018-04-16 | 2018-07-13 | Long-acting formulations |
Country Status (2)
| Country | Link |
|---|---|
| EA (1) | EA202090287A1 (en) |
| PT (2) | PT3651736T (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230355606A1 (en) * | 2020-07-09 | 2023-11-09 | Janssen Pharmaceutica Nv | Long-acting formulations |
-
2018
- 2018-07-13 PT PT187398565T patent/PT3651736T/en unknown
- 2018-07-13 EA EA202090287A patent/EA202090287A1/en unknown
- 2018-07-13 PT PT211785266T patent/PT3943070T/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT3651736T (en) | 2021-09-24 |
| EA202090287A1 (en) | 2020-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE064651T2 (en) | Long-acting formulations of bedaquiline | |
| PL3474822T3 (en) | Formulations of brincidofovir | |
| GB201809976D0 (en) | Novel formulations | |
| IL272857A (en) | Formulations of copanlisib | |
| GB201707189D0 (en) | Novel formulations | |
| IL280906A (en) | Formulations of ag10 | |
| ZA201905379B (en) | 1-amino-1-cyclopropanecaboxylic acid formulations | |
| GB201905477D0 (en) | Novel formulations | |
| GB201707188D0 (en) | Novel formulations | |
| IL284691A (en) | Formulations | |
| IL283593A (en) | Oral formulations of branaplam | |
| GB201707187D0 (en) | Novel formulations | |
| PT3678644T (en) | Formulations of copanlisib | |
| PT3943070T (en) | Long-acting formulations of bedaquiline | |
| HK40120600A (en) | Formulations of brincidofovir | |
| HK40115807A (en) | Formulations of brincidofovir | |
| HK40105712A (en) | Formulations of brincidofovir | |
| SG11202011823SA (en) | Activator-nucleator formulations | |
| GB201911063D0 (en) | Formulations | |
| GB201819028D0 (en) | Butanol-based formulations | |
| GB201905105D0 (en) | Formulations | |
| GB201808386D0 (en) | Formulations | |
| GB201804545D0 (en) | Formulations | |
| GB201803201D0 (en) | Formulations | |
| GB201716291D0 (en) | Novel formulations |